Investigators at seven universities and orthopedic surgery centers in the US studied 351 patientsaged 45 years or older who had a meniscal tear and mild-to-moderate osteoarthritis of the knee.
Further, the vaccine received World Health Organization qualification for use in adults aged 50 years and above, which means WHO member countries can now use the vaccine for older patients.